Muco-Obstructive Lung Disease: A Systematic Review.
copd
cystic fibrosis
infection
muco ciliary clearance
mucus
non-cystic fibrosis bronchiectasis
obstructive lung disease
primary ciliary dyskinesia
respiratory tract
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
19
08
2023
accepted:
11
10
2023
medline:
13
11
2023
pubmed:
13
11
2023
entrez:
13
11
2023
Statut:
epublish
Résumé
Muco-obstructive lung disease is a new classification under the diseases of respiratory tract. A lot of discussion is still going on regarding this new group of diseases. It is characterised by obstruction of the respiratory tract with a thick mucin layer. Usually in normal individuals, the mucus is swept out of the respiratory system while coughing in the form of sputum or phlegm, but if the consistency of the mucus is thick, or the amount is heavy or there is a certain defect in the ciliary function of the respiratory tract, the mucus is not cleared and it gets accumulated in the lungs alveoli, therefore blocking it. The mucus trapped in the distal airways cannot be cleared by coughing therefore forming a layer in the alveoli and bronchioles. Long-standing condition causes inflammation and infection. This new group of diseases specifically includes chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), primary ciliary dyskinesia (PCD) and non-cystic fibrosis bronchiectasis (NCFB). Asthma, although an obstructive disease of the lung, is not particularly included under muco-obstructive lung disease. The major symptoms with which these diseases present are sputum production, chronic cough and acute exacerbations of the condition. The mucus adheres to the lung parenchyma causing airway obstruction and hyperinflation. In this article, we will see how muco-obstructive lung diseases affect the normal physiology of the respiratory system and how is it different from other obstructive and restrictive lung diseases. We will individually look into all the four conditions that come under the category of muco-obstructive lung diseases.
Identifiants
pubmed: 37954759
doi: 10.7759/cureus.46866
pmc: PMC10637992
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e46866Informations de copyright
Copyright © 2023, Singh et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Invest. 2014 Jul;124(7):3047-60
pubmed: 24892808
Chest. 2017 May;151(5):982-992
pubmed: 27889361
N Engl J Med. 2010 Dec 2;363(23):2233-47
pubmed: 21121836
Mucosal Immunol. 2017 Mar;10(2):395-407
pubmed: 27435107
Int J Chron Obstruct Pulmon Dis. 2017 May 11;12:1401-1411
pubmed: 28546748
Curr Opin Pharmacol. 2018 Dec;43:152-165
pubmed: 30340955
Chest. 2006 Jan;129(1):118-23
pubmed: 16424421
Am J Respir Crit Care Med. 2006 May 1;173(9):991-8
pubmed: 16474030
Am J Respir Crit Care Med. 2010 Sep 1;182(5):598-604
pubmed: 20522794
N Engl J Med. 2017 Sep 7;377(10):911-922
pubmed: 28877023
J Clin Invest. 2002 Feb;109(3):317-25
pubmed: 11827991
N Engl J Med. 2019 May 16;380(20):1941-1953
pubmed: 31091375
Am J Respir Crit Care Med. 2015 Jul 15;192(2):182-90
pubmed: 25909230
J Pediatr. 2001 Sep;139(3):359-65
pubmed: 11562614
N Engl J Med. 2006 Jan 19;354(3):229-40
pubmed: 16421364
Paediatr Respir Rev. 2016 Mar;18:18-24
pubmed: 26476603
Thorax. 2007 Apr;62(4):360-7
pubmed: 17387214
Clin Chest Med. 2016 Sep;37(3):449-61
pubmed: 27514592
Thorax. 1952 Sep;7(3):213-39
pubmed: 12984409
Thorax. 2000 Mar;55(3):198-204
pubmed: 10679538
Respir Res. 2019 Aug 28;20(1):199
pubmed: 31462235
Physiol Rev. 2017 Apr;97(2):529-552
pubmed: 28151425
J Physiol. 2010 Jun 15;588(Pt 12):2255-67
pubmed: 20421285
Eur Respir J. 2005 Apr;25(4):640-6
pubmed: 15802337
Sci Signal. 2013 Jun 11;6(279):ra46
pubmed: 23757023
N Engl J Med. 2011 Nov 3;365(18):1663-72
pubmed: 22047557
Lancet. 2018 Sep 8;392(10150):880-890
pubmed: 30215383
Am J Respir Crit Care Med. 2006 Mar 1;173(5):475-82
pubmed: 16126935
PLoS One. 2017 Feb 7;12(2):e0170622
pubmed: 28170403
Am J Respir Crit Care Med. 2008 Apr 15;177(8):853-60
pubmed: 18202344
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12501-12506
pubmed: 30420506
Sci Transl Med. 2019 Apr 3;11(486):
pubmed: 30944166
Sci Transl Med. 2019 Aug 7;11(504):
pubmed: 31391319
N Engl J Med. 2006 Jan 19;354(3):241-50
pubmed: 16421365
Respir Med. 2006 Dec;100(12):2183-9
pubmed: 16650970
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
Adv Drug Deliv Rev. 2018 Aug;133:45-56
pubmed: 29626547